Trump’s trade deal with the E.U. may lead to higher prices for brand-name drugs in the U.S., including the blockbuster ...

AstraZeneca's efforts are paying off as strong U.S. demand, and robust sales of newer cancer, heart and kidney disease ...

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more ...

GSK CEO Emma Walmsley said on a call with journalists after the company posted second-quarter profits above analyst expectations that the discussions with the U.S. administration are "about how to ...

Medicare is negotiating the prices of 15 drugs, including Novo Nordisk's Ozempic. The government has until Nov. 30 to announce the agreed-upon Medicare prices.

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times higher than the prices in 33 OECD countries.

President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to the artificially low, government-set prices in other developed nati… ...

What would Trump’s executive order do? Referring to high U.S. drug prices, Trump told Hannity that “I ended it” by issuing the executive order. But that’s not how the order is structured.

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on ...

Prescription drug prices still surging despite efforts by federal government Consumers spent $61 billion on out-of-pocket prescriptions last year, per GoodRX Prescription Cost Tracker Comments ...